leisure time -WSS

leisure time

author：explore 2025-10-02 00:52:11 - browse：81

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： There’s a way to spot data fakery. All journals should be using it

WSS

A new ‘biological computer' targets cancer while sparing healthy cells

PBM reforms clear House panel

Stanford president’s abrupt resignation sparks debate

In key trial, Verve's treatment lowers cholesterol levels in patients

The stock market has soared this year, but will it last? Experts weigh in

Scientists grapple with ethics of stem cell research

hotspot

leisure time

hotspot

Psychedelics group wrestles with new pharma identity

NYU radiologists take on the challenge of expensive MRI machines

Medical records are filled with copy

NYU radiologists take on the challenge of expensive MRI machines

Malaria cases in Florida and Texas: Here’s what you need to know

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Mystery swirls around US soldier who entered North Korea days ago, officials say

United colonoscopy coverage change 'may cost lives,' doctors say

PBM reforms clear House panel

entertainment

Hormonal contraceptives don’t actually treat endometriosis

FDA's Woodcock to retire early next year

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Caribou posts encouraging results on off

FDA's Woodcock to retire early next year

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

explore

hotspot

focus

hotspot